semaglutide and ulcerative colitis Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse Does Ozempic Cause or Worsen

Southern Medical Association

Ro C, Chai W, Yu VE et al (2013) Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment

Many semaglutide users report fatigue, particularly in the early weeks when caloric intake drops significantly due to appetite suppression

Start your intake How GLP-1 Medications Trigger Gastrointestinal Changes GLP-1 receptor agonists slow gastric emptying and increase colonic fluid secretion, both mechanisms contributing to improved blood sugar control

Peptide Therapy Explore physician-guided Wolverine Blend peptide therapy with BPC-157 and TB-500 for eligible patients interested in recovery support, tissue support, mobility, and wellness-focused care